Who cares about Myring.
Waste of time and money distributing even
if approval gained.
Mayne began journey of Nuvaring ( generic)
Feb 2017. Seriously for a generic. Already 3-4
other on market. The only way to market a
generic is price . So why bother if cost surpasses
revenue.
Who cares about Myring.Waste of time and money distributing...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |